[
  {
    "ts": "2025-12-15T12:42:46+00:00",
    "headline": "The Best Dividend Stocks for Retirement Portfolios in 2026",
    "summary": "Retirement portfolios need growing income that outpaces inflation and safety that lets you sleep at night. The best retirement dividend stocks build reliable income streams that compound for decades. These companies raise dividends through recessions, market crashes, and business disruptions. We ranked them by dividend growth consistency, payout sustainability, and business resilience heading into 2026. ... The Best Dividend Stocks for Retirement Portfolios in 2026",
    "url": "https://247wallst.com/investing/2025/12/15/the-best-dividend-stocks-for-retirement-portfolios-in-2026/",
    "source": "24/7 Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "7f2f9411-920e-3774-9573-78eafb9e2a58",
      "content": {
        "id": "7f2f9411-920e-3774-9573-78eafb9e2a58",
        "contentType": "STORY",
        "title": "The Best Dividend Stocks for Retirement Portfolios in 2026",
        "description": "",
        "summary": "Retirement portfolios need growing income that outpaces inflation and safety that lets you sleep at night. The best retirement dividend stocks build reliable income streams that compound for decades. These companies raise dividends through recessions, market crashes, and business disruptions. We ranked them by dividend growth consistency, payout sustainability, and business resilience heading into 2026. ... The Best Dividend Stocks for Retirement Portfolios in 2026",
        "pubDate": "2025-12-15T12:42:46Z",
        "displayTime": "2025-12-15T12:42:46Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/24_7_wall_st__718/e566f16cf80efd7f1a9e0db51e301c0b",
          "originalWidth": 1500,
          "originalHeight": 1000,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Ar0IGJ6t5R81vJR2J3WCzg--~B/aD0xMDAwO3c9MTUwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/24_7_wall_st__718/e566f16cf80efd7f1a9e0db51e301c0b.cf.webp",
              "width": 1500,
              "height": 1000,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wmEEo6VhW2InbRhiAA4sZQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/24_7_wall_st__718/e566f16cf80efd7f1a9e0db51e301c0b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "24/7 Wall St.",
          "url": "https://247wallst.com/"
        },
        "canonicalUrl": {
          "url": "https://247wallst.com/investing/2025/12/15/the-best-dividend-stocks-for-retirement-portfolios-in-2026/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/best-dividend-stocks-retirement-portfolios-124246339.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "KO"
            },
            {
              "symbol": "XOM"
            },
            {
              "symbol": "PEP"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "PG"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-15T13:30:00+00:00",
    "headline": "Link Cell Therapies Launches with Vision of Advancing CAR-T Therapies in Solid and Liquid Tumors",
    "summary": "Link Cell Therapies (\"Link\"), an oncology cell therapy company, today announced its official launch from stealth with a $60 million Series A financing that was led by Johnson & Johnson, through its corporate venture capital organization, Johnson & Johnson Innovation – JJDC, Inc. , with participation from founding investors Samsara BioCapital and Sheatree Capital, as well as Wing Venture Capital and other new strategic and financial investors.",
    "url": "https://finance.yahoo.com/news/cell-therapies-launches-vision-advancing-133000308.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "b7d2d38f-31f4-3f47-bf19-a5ff3d0785cc",
      "content": {
        "id": "b7d2d38f-31f4-3f47-bf19-a5ff3d0785cc",
        "contentType": "STORY",
        "title": "Link Cell Therapies Launches with Vision of Advancing CAR-T Therapies in Solid and Liquid Tumors",
        "description": "",
        "summary": "Link Cell Therapies (\"Link\"), an oncology cell therapy company, today announced its official launch from stealth with a $60 million Series A financing that was led by Johnson & Johnson, through its corporate venture capital organization, Johnson & Johnson Innovation – JJDC, Inc. , with participation from founding investors Samsara BioCapital and Sheatree Capital, as well as Wing Venture Capital and other new strategic and financial investors.",
        "pubDate": "2025-12-15T13:30:00Z",
        "displayTime": "2025-12-15T13:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/68e1502f0457e9f3c4855cb1499b8a9c",
          "originalWidth": 348,
          "originalHeight": 208,
          "caption": "Link Cell Therapies",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/cvToM5uK5gBEJD5yXcj2yw--~B/aD0yMDg7dz0zNDg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/68e1502f0457e9f3c4855cb1499b8a9c.cf.webp",
              "width": 348,
              "height": 208,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SD9vBljMg_BGW5ziESf78Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/68e1502f0457e9f3c4855cb1499b8a9c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/cell-therapies-launches-vision-advancing-133000308.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/cell-therapies-launches-vision-advancing-133000308.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]